☆ 4.7 Editorial Material

Molecular Mechanisms Underlying Chronic and Degenerative Diseases

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Behavioral Sciences

In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's disease

Philip Wing-Lok Ho et al.

Summary: The expression of SYNGR3 plays an important role in the balance of DA and synaptic function in the brain. Inducing SYNGR3 expression in a mutant LRRK2 mouse model improved synaptic DA uptake and innate behavior, suggesting that SYNGR3 may have an influence on the pathophysiology of DA neurons in PD.

BRAIN AND BEHAVIOR (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

Hanan Ehtewish et al.

Summary: Dementia is a progressive and debilitating neurological disease. Proteomic studies have revealed potential protein biomarkers for dementia. This pilot study used a high-throughput proximity extension immunoassay to quantify proteins in plasma and identified diagnostic biomarkers for dementia with high accuracy. Dysregulation of plasma proteins and correlation with cognitive performance suggest potential mechanisms and pathways in dementia pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway

Zhen Wang et al.

Summary: BPH is a common disease in elderly men and is closely related to MetS. This study demonstrates that SV can modulate cell proliferation, apoptosis, tissue fibrosis, and the EMT process in the prostate through crosstalk between PPAR gamma and WNT/beta-catenin pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Galectin 1-A Key Player between Tissue Repair and Fibrosis

Anca Hermenean et al.

Summary: This article highlights the role of Gal-1 in wound healing and fibrotic diseases, suggesting its potential as a therapeutic target and biomarker.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Myocardial GRK2 Reduces Fatty Acid Metabolism and β-Adrenergic Receptor-Mediated Mitochondrial Responses

Ruxu Zhai et al.

Summary: GRK2 is upregulated in heart failure and cardiac disease models, which reduces mitochondrial respiratory function and responses to beta-AR activation. Upregulation of GRK2 promotes palmitate-induced cell death and impairs ISO-mediated mitochondrial function.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression

Lingfei Li et al.

Summary: This study investigated whether NURR1 can regulate the expression of SYNGR3. In silico analysis and experimental validation revealed that NURR1 can bind to the cis-acting sites of the SYNGR3 gene and activation of NURR1 can increase the expression of SYNGR3. This finding suggests that inducing SYNGR3 expression by activating NURR1 may be a potential therapeutic strategy to attenuate synaptic dysfunction in Parkinson's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Dorsolateral Prefrontal Cortex Glutamate/Gamma-Aminobutyric Acid (GABA) Alterations in Clinical High Risk and First-Episode Schizophrenia: A Preliminary 7-T Magnetic Resonance Spectroscopy Imaging Study

Ahmad Mayeli et al.

Summary: Evidence suggests that there is an imbalance between excitation and inhibition in the dorsolateral prefrontal cortex of individuals with schizophrenia. This study utilized magnetic resonance spectroscopic imaging to investigate the levels of gamma-aminobutyric-acid (GABA) and glutamate (Glu) in the DLPFC of schizophrenia patients, particularly on the right hemisphere. The findings suggest that abnormalities in GABA and Glu are present in the early stages of illness, serving as potential biomarkers for schizophrenia and related psychotic disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line

Clara Ruz et al.

Summary: Mutations in LRRK2 and GBA1 contribute to the genetic risk of developing Parkinson's disease. This study investigates the interaction between LRRK2 kinase activity and GBA, and how it affects lysosomal dysfunctions in PD. The results suggest that LRRK2 kinase activity may regulate lysosomal function and play a role in GBA protein levels and autophagy activation. Enhancing GCase activity could potentially restore defective protein metabolism in PD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease

Jonas Folke et al.

Summary: This study investigates the autoimmune aberrancies towards alpha-synuclein in prodromal phases of multiple-system trophy and Parkinson's Disease. The results indicate impaired reactivity towards alpha-synuclein occurs before disease onset, which may result in reduced clearance and aggregation of the protein.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Multidisciplinary Sciences

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients

Daniel Ysselstein et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Review Pharmacology & Pharmacy

GRK2 as a therapeutic target for heart failure

Alessandro Cannavo et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2018)

Add to Collection

Article Urology & Nephrology

The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome

Xiangyu Zhang et al.

WORLD JOURNAL OF UROLOGY (2015)

Add to Collection

Article Urology & Nephrology

Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort

Pourya Pashootan et al.

BJU INTERNATIONAL (2015)

Add to Collection

Article Urology & Nephrology

Impact of Metabolic Syndrome on Benign Prostatic Hyperplasia in Elderly Chinese Men

Xiangyu Zhang et al.

UROLOGIA INTERNATIONALIS (2014)

Add to Collection

Article Urology & Nephrology

The Relationship Between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and the Number of Components of Metabolic Syndrome

Yeon Won Park et al.

UROLOGY (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.